首页> 美国卫生研究院文献>Interdisciplinary Toxicology >Antiproliferative neurotoxic genotoxic and mutagenic effects of toxic cyanobacterial extracts
【2h】

Antiproliferative neurotoxic genotoxic and mutagenic effects of toxic cyanobacterial extracts

机译:有毒的蓝细菌提取物的抗增殖神经毒性遗传毒性和诱变作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cyanobacteria are the rich resource of various secondary metabolites including toxins with broad pharmaceutical significance. The aim of this work was to evaluate the antiproliferative, neurotoxic, genotoxic and mutagenic effects of cyanobacterial extracts containing Microcystin-LR (MCLR) . ELISA analysis results showed that MCLR contents of five cyanobacterial extracts were 2.07 ng/mL, 1.43 ng/mL, 1.41 ng/mL, 1.27 ng/mL, and 1.12 ng/mL for sp. SB1, sp. SB4, SB5, sp. SB2, Uncultured , respectively. sp. SB4 and sp. SB2 extracts had the lowest neurotoxicity (86% and 79% cell viability, respectively) and SB5 extracts had the highest neurotoxicity (47% cell viability) on PC12 cell at 1000 µg/ml extract concentration. sp. SB1 and sp. SB2 showed the highest antiproliferative effect (92% and 77% cell death) on HT29 cell. On the other hand, all concentrations of five toxic cyanobacterial extracts induced DNA damage between 3.0% and 1.3% of tail intensity and did not cause any direct mutagenic effect at the 1000 µg/plate cyanobacterial extracts. These results suggest that cyanobacteria-derived MCLR is a promising candidate for development of effective agents against colon cancer.
机译:蓝细菌是各种次生代谢产物的丰富资源,包括具有广泛药学意义的毒素。这项工作的目的是评估含有微囊藻毒素-LR(MCLR)的蓝细菌提取物的抗增殖,神经毒性,遗传毒性和诱变作用。 ELISA分析结果表明,五种蓝藻提取物的MCLR含量分别为2.07 ng / mL,1.43 ng / mL,1.41 ng / mL,1.27 ng / mL和1.12 ng / mL。 SB1,sp。 SB4,SB5,sp。 SB2,未培养。 sp。 SB4和sp。在浓度为1000 µg / ml的PC12细胞上,SB2提取物具有最低的神经毒性(分别为86%和79%细胞活力),SB5提取物具有最高的神经毒性(47%细胞活力)。 sp。 SB1和sp。 SB2对HT29细胞显示出最高的抗增殖作用(92%和77%的细胞死亡)。另一方面,所有浓度的五种有毒蓝细菌提取物均会引起尾巴强度在3.0%和1.3%之间的DNA损伤,并且在1000 µg /板蓝细菌提取物中不会引起任何直接诱变作用。这些结果表明,源自蓝细菌的MCLR是开发抗结肠癌有效药物的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号